Avigen: Clinical Trials

4 trials sponsored by Avigen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 1 completed. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 3, Completed 1
Phase 12Completed 1, Terminated 1

Follow Avigen: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
tolperisone HCl (AV650), Placebo - Muscle Spasticity
Phase 2TerminatedAvigen1202007-09-012008-11-04
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
tolperisone HCl - Muscle Spasticity
Phase 2TerminatedAvigen1502007-09-012008-11-04
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain
AV411 - Diabetic Neuropathy
Phase 1 / Phase 2CompletedAvigen362006-09-012007-12-19
Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B
Adeno-Associated Viral with Human Factor IX - Hemophilia B
Phase 1 / Phase 2TerminatedAvigen152004-01-012007-04-04

Conditions studied

Muscle Spasticity (2)  ·  Diabetic Neuropathies (1)  ·  Hemophilia B (1)  ·  Multiple Sclerosis (1)  ·  Spinal Cord Injuries (1)

Interventions

Tolperisone (2)  ·  ibudilast (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Russia (1)  ·  Serbia (1)  ·  Ukraine (1)

Top investigators

Glenn Morrison, MSc, PhD (1)  ·  Ralph J Marino, MD (1)